The SMC Group and EMCVPA Partner to Boost Jamaica’s Creative Industries
30.6.2021 17:00:00 EEST | Business Wire | Press release
Jamaica’s creative sector has received a major boost through a partnership between global entertainment marketing agency, The SMC Group, and The Edna Manley College of the Visual and Performing Arts (EMCVPA). This arrangement aims to foster the development of Jamaican talent and the island’s Creative Industries.
The venture will begin with an investment into the development of a music production studio to support local song writers, producers, and artistes. SMC also intends to recruit EMCVPA students for apprenticeships and job placements. This ground-breaking initiative will enhance the music and audio production, animation, as well as dance specialisations at the College.
The partnership is the latest positive development in the island’s creative industries which have seen considerable growth in recent years.
In the film industry, more than 4000 film-related jobs have been created in the last three years while approximately 150 foreign productions are facilitated per year. Over 3 billion JMD in film production expenditure was contributed to GDP in the last two years, and approximately 65-70 percent of crews hired on most international film productions in Jamaica are local.
The country also has a growing animation industry with 15 local studios having participated in government-led programmes to increase their profitability and sustainability.
CEO of The SMC Group, Maurice Hamilton, revealed that the collaboration between the group and EMCVPA will add to the progress that has already been made in the creative industries by expanding investment into the areas of talent and content in the music and audio-visual sectors.
“This is the first step of an exciting initiative to establish Jamaica and then the wider Caribbean region as a creative hub that will develop creative and business professionals as well as content,” the CEO remarked. “And for SMC, it creates a solid, efficient pipeline of creative talent to service our global clients.”
The CEO also disclosed that SMC intends to build a centre of excellence in Jamaica and will be engaging in additional investments and local partnerships.
“We want to ensure that our commitment to Jamaican talent is substantive,” he insisted. “Through greater education, funding, and through our network within the global marketplace we can provide a platform from which Jamaican talent can flourish internationally.”
The island has seen several ventures over the years led by the private sector, public sector or both, which seek to advance the creative industry. Programmes such as the Business of Sustainability for Studios (BOSS) programme, JAFTA Propella film development programme, and the Film Lab initiative help entrepreneurs grow their animation and film production studios, and increase content development.
In the spirit of these collaborations between industry stakeholders, Diane Edwards, President of Jamaica’s investment and export promotions agency, JAMPRO, welcomed the cooperation between SMC and EMCVPA.
“At JAMPRO, we believe that partnership is essential to building local industries and to creating valuable opportunities for Jamaica’s people, so we are pleased to see this agreement between SMC and Edna Manley College,” she said.
EMCVPA’s Vice Principal of Administration and Resource Development, Ms. Kerry Ann Henry, shared her enthusiasm for the partnership and explained that its objectives were in keeping with the college’s mission. She stated, “This is a partnership that will not just strengthen our respective organizations, it will be of enormous benefit to the country in fields related to the visual and performing arts.”
About The SMC Group
The SMC Group operates in 17 markets across the globe and has worked on campaigns for brands like The Coca-Cola Company, Net-A-Porter, Unilever, Diageo, Cartier and a host of globally recognizable names. Their projects have also involved celebrities like Jamaican Olympian Usain Bolt, Korean pop band BTS, Colombian superstar Maluma and American celebrities such as Kevin Hart, Jason Derulo and Kanye West.
ABOUT JAMPRO
The Jamaica Promotions Corporation (JAMPRO)’s mission is to drive economic development through growth in investment and export. JAMPRO is an Agency of the Ministry of Industry, Investment, and Commerce.
For more information on JAMPRO, please visit https://dobusinessjamaica.com/.
Follow us on:
Twitter
Facebook
Instagram
LinkedIn
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630005271/en/
Contact information
Integrated Marketing Communications
Tamica Parchment
tparchment@jamprocorp.com
Tele: 876-978-7755
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila
PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
